Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Evaluating the efficacy of an active compression brace on orthostatic cardiovascular responses.

Moein H, Jhalli R, Blaber AP, Claydon VE, Menon C.

PLoS One. 2017 Nov 22;12(11):e0187885. doi: 10.1371/journal.pone.0187885. eCollection 2017.

2.

The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancer.

Parsons MF, Foster PA, Chander SK, Jhalli R, Newman SP, Leese MP, Potter BV, Purohit A, Reed MJ.

Br J Cancer. 2008 Nov 4;99(9):1433-41. doi: 10.1038/sj.bjc.6604707. Epub 2008 Oct 7.

3.

Inhibition of steroid sulphatase activity via the percutaneous route: a new option for breast cancer therapy.

Purohit A, Chander SK, Woo LW, Parsons MF, Jhalli R, Potter BV, Reed MJ.

Anticancer Res. 2008 May-Jun;28(3A):1517-23.

4.

In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy.

Foster PA, Newman SP, Chander SK, Stengel C, Jhalli R, Woo LL, Potter BV, Reed MJ, Purohit A.

Clin Cancer Res. 2006 Sep 15;12(18):5543-9.

Supplemental Content

Loading ...
Support Center